DirectHaler™ Pulmonary possess unequalled ease-of-use and manufacturability – without compromising delivery performance.  Performance and characteristics are confirmed in clinical trials (Phase I, II/III) and invitro documentation.

We would be pleased to compile and make additional technical information available for you to evaluate.

Please contact Dr. Troels Keldmann for more details.